DFM Platform
DFM Funding Monitor

Flexible Wearable Bioadhesive Ultrasound Patch for Synergistic Piezoelectric and Acoustic Stimulation in Diabetic Wound Healingcore

FW-BAUS · Horizon Europe grant · 2026-10-01–2028-09-30

EC contribution

€247,553

Total cost

€0

Beneficiaries

2
About the data

Source: CORDIS (official EU open data), Horizon Europe. Framework HORIZON · call HORIZON-MSCA-2025-PF · scheme HORIZON-TMA-MSCA-PF-EF · topic HORIZON-MSCA-2025-PF-01-01. CORDIS record →

Objective

Diabetic foot ulcers (DFUs) present serious clinical and socioeconomic challenges, often becoming chronic wounds that raise morbidity and risk of limb loss. Pharmacological treatments face limitations such as drug resistance, poor delivery, and immune complications, emphasizing the urgent need for effective, noninvasive alternatives. Ultrasound, electrostimulation, and photomodulation are FDA-approved, noninvasive options for tissue engineering. To address this, we propose a flexible wearable bioadhesive ultrasound patch (FW-BAUS) designed to actively modulate the DFU microenvironment. FW-BAUS combines a flexible ultrasound patch with dense piezoelectric transducers embedded in a bioadhesive hydrogel composed of piezoelectric poly-L-lactic acid nanofibers (NF-PLLA), chitosan, gelatin methacryloyl (GelMA), α-ketoglutaric acid, and acrylic acid N-hydroxysuccinimide ester (AAc-NHS). The hydrogel’s physical and covalent bonds allow strong yet reversible adhesion to moist skin, while its bioactive components support cell migration, neovascularization, collagen synthesis, and clotting. NF-PLLA nanofibers synergize with the patch’s piezoelectric elements to provide simultaneous mechanical and electrical stimulation. Ultrasound energy converts in situ into localized electric fields at the wound interface through NF-PLLA, while acoustic radiation force delivers mechanical stimuli. This dual stimulation is expected to accelerate diabetic wound healing. Furthermore, NF-PLLA’s intrinsic antibacterial properties, combined with chitosan’s antimicrobial effects and ultrasound-enhanced bacterial sensitivity, offer potent infection defense, aiding the healing process. Electrospinning aligns NF-PLLA nanofibers to maximize piezoelectricity while minimizing processing steps. By integrating biocompatible adhesion, mechanical-electrical stimulation, and antibacterial activity, FW-BAUS offers an innovative, noninvasive platform to accelerate DFU healing and improve clinical outcomes.

Beneficiaries (2)

OrganisationCountryRoleEC contributionSME
DANMARKS TEKNISKE UNIVERSITET DK coordinator €247,553
UNIVERSIDAD DEL PAIS VASCO/ EUSKAL HERRIKO UNIBERTSITATEA ES associatedPartner

Get the DFM funding briefing — free

New EU defence calls, tenders and awards in your inbox.

Countries
Sectors
Sources

We store your email only to send the DFM briefing/alerts and to add you to DFM Analysis. Unsubscribe anytime.

Defence Finance Monitor is an analytical and informational product. Grant data is official CORDIS; payment and subscription happen on DFM Analysis.